Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years

Published:2021-11-24 Issue:11 Volume:4 Page:e2136008
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Lee Gyeongsil¹,Choi Seulggie²,Chang Jooyoung²,Choi Daein³,Son Joung Sik⁴,Kim Kyuwoong⁵,Kim Sung Min²,Jeong Seogsong²,Park Sang Min¹²

Affiliation:

1. Department of Family Medicine, Seoul National University Hospital, Seoul, Korea

2. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea

3. Department of Medicine, Mount Sinai Beth Israel Icahn School of Medicine at Mount Sinai, New York, New York

4. Department of Family Medicine, Korea University Guro Hospital, Seoul, Korea

5. National Cancer Control Institute, National Cancer Center, Goyang-si, Gyeonggi-do, Korea

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786547/lee_2021_oi_211011_1637099486.37982.pdf

Reference30 articles.

1. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment.;Hugo;Clin Geriatr Med,2014

2. Diagnosis and management of dementia: review.;Arvanitakis;JAMA,2019

3. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.;Parnetti;Mech Ageing Dev,2001

4. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer’s disease with cerebrovascular injury: interim results.;Amenta;J Neurol Sci,2012

5. The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer’s Disease) trial: interim results after two years of treatment.;Amenta;J Alzheimers Dis,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipidomics profiling and circulating triglyceride concentrations in sub-Saharan African individuals;Scientific Reports;2024-09-06

2. Plasma metabolites as potential markers and targets to prevent and treat urolithiasis: a Mendelian randomization study;Frontiers in Molecular Biosciences;2024-08-27

3. Exploring the causal association between genetically determined circulating metabolome and hemorrhagic stroke;Frontiers in Nutrition;2024-05-15

4. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation;EPMA Journal;2024-02-27

5. Latest research in nootropic therapy of patients with chronic cerebral circulation insufficiency;Wiadomości Lekarskie;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3